Role of khadir plant in treating people suffering from anemia.

An Investigation on Khadir (Acacia catechu) as a Potential Haematinic Agent in Phenyl Hydrazine Induced Anaemia in rats and clinical Study on Pandu (Anaemia). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079174

Enrollment

Registered

2025-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) newly diagnosed anemia within 2-6 month. 2) anemia will be considered in this study 6 mg/dl - 9 mg/dl.

Exclusion criteria

Exclusion criteria: 1)any associated severe disease like hiv or tb or malignancy or trauma. 2)any medication like other anti anemic or anti pshycotic or steroids. 4)pregnant and lactating mother

Design outcomes

Primary

Measure	Time frame
to access the haematinic property of khadir by monitoring the sign and symptoms as well as some laboratory investigations like hb% of the patient suffering from pandu rogaTimepoint: sign and symptoms with hb % of the patients will be recorded after treatment after 14 days and finally after 28 days	—

Secondary

Measure	Time frame
effect of the test drug on quality of life among the patients of pandu roga.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Tannawee Singh

Institute of Post Graduate Ayurvedic Education and Research at S.V.S.P

atipgaer@gmail.com9874849650

Outcome results